Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-3 of  3 results for ""Locked nucleic acid""

Your Filters

Content Provider : ClinicalTrials.gov
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma

  • Authors : Jinsong Wu, Chief Physician

  • Source: Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma: A Prospective, Interventional, Multicenter, Randomized Controlled Trial[1]. Weller M, Wick W, Aldape K, et al. Glioma.

Record details

Read More Add to Saved list
×
Report

Phase 1 Study of EZN-2968 Weekly in Adult Patients With Advanced Solid Tumors or Lymphoma

  • Authors : Noah Berkowitz, MD/Medical Monitor

  • Source: A Phase 1, Open-Label, Dose Escalation Study Evaluating the Safety and Tolerability of EZN-2968, a Locked Nucleic

Record details

Read More Add to Saved list
×
Report

A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment (LNA-i-miR221)

  • Source: A Dose Escalation Phase I Study of LNA-i-miR-221 for the Treatment of Refractory Multiple Myeloma and Advanced Solid TumorsDi Martino MT, Arbitrio M, Caracciolo D, Scionti F, Tagliaferri P,

Record details

Read More Add to Saved list
×
  • 1-3 of  3 results for ""Locked nucleic acid""